Peter S. Lawrence

ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA.

Spherics, Inc. develops pharmaceutical products to address the clinical needs of neurological disorders. Its technology is based on proprietary bio adhesive, biodegradable polymers, enhancers, and coatings. The company has established two distinct drug delivery systems: nano and macro spheres. Spherics was founded by Dr. Edith Mathiowitz in 1997 and is located in Mansfield, MA.

Peppercoin, Inc. provides software payment services for merchants. It provides small payments suite for various payment models, including pre-paid, subscription and pay-as-you-go with Intelligent Aggregation. The company serves digital, mobile and physical point-of-sale merchants. Peppercoin was founded in 2001 by Silvio Micali and Ronald Rivest and is located in Waltham, MA.

Pintex Pharmaceuticals, Inc. used to discover and develop cancer therapeutics. The company used to discover and commercialize new antibiotics focused on drug resistance. Pintex Pharmaceuticals was founded by Walter Gilbert, Kung Ping Lu and Janusz Sowadski in 1999 and was headquartered in Watertown, MA.

Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA.

Founded in 2000, Pod Holding, Inc. is a private equity firm headquartered in Boston with an additional presence in Stockholm.

Pod Investment AB (Pod) is an independent venture capital investment firm with offices in Stockholm, Sweden, and Boston, Massachusetts. The firm was founded in 2000. Pod specializes in funding early and mid-stage investments, syndicating later-stage investments in corporate spin-outs, MBOs, recapitalizations, and privatizations of more mature firms.

Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA.